Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FGFR3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | FGFR3 |
| Aliases | Page for FGFR3 |
| Chromosome | 4p16.3 |
| Protein Family | FGFR tyrosine kinase family |
| Protein Type | Receptor |
| Function | FGFR3 (Fibroblast Growth Factor Receptor 3) is a receptor tyrosine kinase that binds FGFs. |
| Primary Expression | chondrocytes where it negatively regulates bone growth, explaining why activating FGFR3 mutations cause achondroplasia, the most common form of dwarfi |
| Molecular Weight | 88.5 kDa |
| Amino Acids | 808 aa |
| Exons | 19 |
| Pathways | MAPK, PI3K |
| UniProt ID | P22607 |
| GeneCards | FGFR3 |
| Human Protein Atlas | FGFR3 |
| Extracellular Domain | Contains three immunoglobulin-like domains (D1-D3) that mediate FGF binding |
| Associated Diseases | Als, bladder cancer, Breast Cancer, cancer, Carcinoma |
| Interactions | AND, BMPR1A, CANCER, EP300, KDM6A, KMT2D |
| KG Connections | 98 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
FGFR3["FGFR3"]
bladder_cancer{"bladder cancer"}
FGFR3 -->|"causes"| bladder_cancer
TP53["TP53"]
FGFR3 -->|"interacts with"| TP53
RB1["RB1"]
FGFR3 -->|"interacts with"| RB1
Cancer{"Cancer"}
FGFR3 -->|"therapeutic target"| Cancer
Als{"Als"}
FGFR3 -->|"associated with"| Als
Tumor{"Tumor"}
FGFR3 -->|"associated with"| Tumor
FGFR3 -->|"therapeutic target"| Tumor
Ms{"Ms"}
FGFR3 -->|"therapeutic target"| Ms
Glioblastoma{"Glioblastoma"}
FGFR3 -->|"therapeutic target"| Glioblastoma
FGFR3 -->|"associated with"| Cancer
Aging{"Aging"}
FGFR3 -->|"activates"| Aging
FGFR3 -->|"activates"| Ms
BMPR1A["BMPR1A"]
BMPR1A -->|"interacts with"| FGFR3
RB1 -->|"associated with"| FGFR3
OVERVIEW["OVERVIEW"]
OVERVIEW -->|"therapeutic target"| FGFR3
TP53 -->|"associated with"| FGFR3
CDK4["CDK4"]
CDK4 -->|"associated with"| FGFR3
TEAD1["TEAD1"]
TEAD1 -->|"therapeutic target"| FGFR3
EGFR["EGFR"]
EGFR -->|"associated with"| FGFR3
KDM4A["KDM4A"]
KDM4A -->|"associated with"| FGFR3
EP300["EP300"]
EP300 -->|"activates"| FGFR3
GENES["GENES"]
GENES -->|"therapeutic target"| FGFR3
IDH1["IDH1"]
IDH1 -->|"associated with"| FGFR3
NF1["NF1"]
NF1 -->|"associated with"| FGFR3
style FGFR3 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| bladder cancer | causes | disease | 0.90 |
| Cancer | therapeutic_target | disease | 0.85 |
| Tumor | associated_with | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Tumor | therapeutic_target | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| CANCER | therapeutic_target | gene | 0.70 |
| OVERVIEW | therapeutic_target | gene | 0.70 |
| CANCER | associated_with | gene | 0.70 |
| KRAS | associated_with | gene | 0.70 |
| TP53 | associated_with | gene | 0.70 |
| TP53 | interacts_with | gene | 0.70 |
| RB1 | interacts_with | gene | 0.70 |
| GENES | therapeutic_target | gene | 0.70 |
| Glioblastoma | therapeutic_target | disease | 0.65 |
| Myeloma | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Coronary Artery Disease | therapeutic_target | disease | 0.65 |
| Longevity | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Leukemia | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Cancer | biomarker_for | disease | 0.65 |
| Carcinoma | biomarker_for | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Breast Cancer | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Pancreatic Cancer | associated_with | disease | 0.65 |
| TFAP4 | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| NF1 | associated_with | gene | 0.60 |
| RAS | expressed_in | gene | 0.60 |
| DNA | biomarker_for | gene | 0.60 |
| Immune Checkpoint | associated_with | pathway | 0.60 |
| Checkpoint Inhibitor | associated_with | pathway | 0.60 |
| Immunotherapy | associated_with | pathway | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| IDH1 | associated_with | gene | 0.60 |
| BICD2 | associated_with | gene | 0.60 |
| MITF | associated_with | gene | 0.60 |
| HSPA1A | associated_with | gene | 0.60 |
| BRCA2 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BMPR1A | interacts_with | gene | 0.70 |
| GENES | therapeutic_target | gene | 0.60 |
| GLIOBLASTOMA | therapeutic_target | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| RB1 | associated_with | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| KDM4A | associated_with | gene | 0.60 |
| EP300 | activates | gene | 0.60 |
| KMT2D | therapeutic_target | gene | 0.60 |
| PIK3CA | associated_with | gene | 0.60 |
| KDM6A | therapeutic_target | gene | 0.60 |
| CDK4 | associated_with | gene | 0.60 |
| TEAD1 | therapeutic_target | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| FGFR1 | translocates_to | gene | 0.60 |
| AND | activates | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| IDH1 | associated_with | gene | 0.60 |
| NF1 | associated_with | gene | 0.60 |
| OVERVIEW | activates | gene | 0.60 |
| KMT2D | activates | gene | 0.60 |
| KDM6A | activates | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning FGFR3 in their description or question text
No additional research found